Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Digestive Neuroendocrine Tumors × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 46 Neoplasms 8 Carcinoid Tumor 7 Neoplasm Metastasis 5 Gastro-enteropancreatic neuroendocrine tumor 5 Pancreatic Neoplasms 3 Neuroectodermal Tumors, Primitive 3 Gastrointestinal Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Neuroendocrine 3 Adenoma, Islet Cell 3 Thyroid Neoplasms 2 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Serotonin Syndrome 2 Sarcoma 2 Pheochromocytoma 2 Paraganglioma 2 Neuroblastoma 2 Neoplasms by Site 2 Digestive System Neoplasms 2 Digestive System Diseases 2 Cholangiocarcinoma 2 Carcinoma, Islet Cell 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Adrenal Gland Neoplasms 2 von Hippel-Lindau Disease 1 Vipoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465112 2019-02-28

TERAVECT

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Terminated

Digestive Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡